Basic & Clinical Medicine ›› 2022, Vol. 42 ›› Issue (10): 1616-1620.doi: 10.16352/j.issn.1001-6325.2022.10.1616
• Mini Reviews • Previous Articles Next Articles
LI Shuang, LI Yang*
Received:
2021-05-17
Revised:
2021-10-09
Online:
2022-10-05
Published:
2022-09-23
Contact:
* liyanghmu@163.com
CLC Number:
LI Shuang, LI Yang. Research progress on the role of colon rectal neoplasia differentially expressed RNA in diseases[J]. Basic & Clinical Medicine, 2022, 42(10): 1616-1620.
[1] | Schmitt AM,Chang HY. Long noncoding RNAs in cancer pathways[J]. Cancer Cell,2016,29:452-463. |
[2] | Ma XF,Zhang W,Zhang R,et al. Overexpressed long noncoding RNA CRNDE with distinct alternatively spliced isoforms in multiple cancers[J]. Front Med, 2019, 13: 330-343. |
[3] | Wang W,Yuan F,Xu J.The prognostic role of long noncoding RNA CRNDE in cancer patients: a systematic review and meta-analysis[J].Neoplasma, 2019, 66: 73-82. |
[4] | Schaefer KN, Peifer M. Wnt/Beta-catenin signaling regulation and a role for biomolecular condensates[J]. Dev Cell,2019,48:429-444. |
[5] | Huan JL,Xing L,Lin QH,et al. Long noncoding RNA CRNDE activates Wnt/β-catenin signaling pathway through acting as a molecular sponge of microRNA-136 in human breast cancer[J]. Am J Transl Res, 2017, 9: 1977-1989. |
[6] | Yang FY,Wang Y,Wu JG,et al. Analysis of long non-coding RNA expression profiles in clear cell renal cell carcinoma[J]. Oncol Lett, 2017, 14: 2757-2764. |
[7] | Fu DW,Zang L,Li ZW, et al. Long non-coding RNA CRNDE regulates the growth and migration of prostate cancer cells by targeting microRNA-146a-5p[J].Bioengineered, 2021, 12: 2469-2479. |
[8] | Jing H, Xia H, Qian M,et al. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p[J]. Biomed Pharmacother, 2019,110:825-833. |
[9] | Ji DG,Jiang CW,Zhang LR,et al. LncRNA CRNDE promotes hepatocellular carcinoma cell proliferation, inva-sion, and migration through regulating miR-203/ BCAT1 axis[J].J Cell Physiol, 2019, 234: 6548-6560. |
[10] | Ren Y, He W, Chen W, et al. CRNDE promotes cell tongue squamous cell carcinoma cell growth and invasion through suppressing miR-384[J]. J Cell Biochem,2019,120:155-163. |
[11] | Zhu HY,Gao YJ,Wang Y,et al. LncRNA CRNDE promotes the progression and angiogenesis of pancreatic cancer via miR-451a/CDKN2D axis[J].Transl Oncol, 2021, 14: 101088.doi: 10.1016/j.tranon.2021.101088. |
[12] | Yu YL,Wang LM,Li ZJ,et al. Long noncoding RNA CRNDE functions as a diagnostic and prognostic biomarker in osteosarcoma, as well as promotes its progression via inhibition of miR-335-3p[J]. J Biochem Mol Toxicol, 2021, 35: e22734.doi: 10.1002/jbt.22734. |
[13] | Zheng J,Liu XB,Wang P,et al. CRNDE promotes malignant progression of glioma by attenuating miR-384/PIWIL4/STAT3 axis[J]. Mol Ther, 2016, 24: 1199-1215. |
[14] | Ding J,Li J,Wang HY,et al. Long noncoding RNA CRNDE promotes colorectal cancer cell proliferation via epigenetically silencing DUSP5/CDKN1A expression[J]. Cell Death Dis, 2017, 8: e2997.doi: 10.1038/cddis.2017.328. |
[15] | 黄海良,丁伟伟,李冬雪.CRNDE过表达促进人肝癌细胞系HepG2增殖和迁移[J].基础医学与临床,2020,40:219-223. |
[16] | Xie SC,Zhang JQ,Jiang XL,et al. LncRNA CRNDE facilitates epigenetic suppression of CELF2 and LATS2 to promote proliferation, migration and chemoresistance in hepatocellular carcinoma[J]. Cell Death Dis, 2020, 11: 676.doi: 10.1038/s41419-020-02853-8. |
[17] | Liu C,Hou JF,Shan FX,et al. Long non-coding RNA CRNDE promotes colorectal carcinoma cell progression and paclitaxel resistance by regulating miR-126-5p/ATAD2 axis[J].Onco Targets Ther, 2020, 13: 4931-4942. |
[18] | Zhang FF,Wang H,Yu J, et al. LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regula-ted alternative splicing of PICALM[J].Mol Cancer, 2021, 20: 6.doi: 10.1186/s12943-020-01299-y. |
[19] | Takahashi S,Noro R,Seike M,et al. Long non-coding RNA CRNDE is involved in resistance to EGFR tyrosine kinase inhibitor in EGFR-mutant lung cancer via eIF4A3/MUC1/EGFR signaling[J].Int J Mol Sci, 2021, 22: 4005.doi: 10.3390/ijms22084005. |
[20] | Zhu GD,Yang YP,Jiang ZJ.Knockdown CRNDE alleviates LPS-induced inflammation injury via FOXM1 in WI-38 cells[J]. Biomed Pharmacother, 2018, 103: 1678-1687. |
[21] | Cheng LX,Nan CC,Kang L,et al. Whole blood transcriptomic investigation identifies long non-coding RNAs as regulators in sepsis[J]. J Transl Med, 2020, 18: 217.doi: 10.1186/s12967-020-02372-2. |
[22] | Li Y,Song JF,Xie ZC,et al. Long noncoding RNA colorectal neoplasia differentially expressed alleviates sepsis-induced liver injury via regulating miR-126-5p[J]. IUBMB Life, 2020, 72: 440-451. |
[23] | Zhu Y,Sun AC,Meng TC,et al. Protective role of long noncoding RNA CRNDE in myocardial tissues from injury caused by sepsis through the microRNA-29a/SIRT1 axis[J]. Life Sci, 2020, 255: 117849.doi: 10.1016/j.lfs.2020.117849. |
[24] | Zheng DZ,Zhang Y,Hu YH,et al. Long noncoding RNA Crnde attenuates cardiac fibrosis via Smad3-crnde negative feedback in diabetic cardiomyopathy[J]. FEBS J, 2019, 286: 1645-1655. |
[25] | Mulati M,Kobayashi Y,Takahashi A,et al. The long noncoding RNA Crnde regulates osteoblast proliferation through the Wnt/β-catenin signaling pathway in mice[J].Bone, 2020, 130: 115076. doi: https://doi.org/10.1016/j.bone.2019.115076. |
[1] | MENG Dequan, QIN Xin, CHEN Ling, QIN Jun. Polysaccharides from Atractylodes macrocephala koidz. inhibit inflammatory response in rat model of severe pneumonia [J]. Basic & Clinical Medicine, 2024, 44(9): 1263-1268. |
[2] | JIANG Su, LYU Xinxiang, CUI Yanhong, LYU Liting, LI Dongxia. Therapeutic effect of evodiamine on atopic dermatitis in rat models [J]. Basic & Clinical Medicine, 2024, 44(9): 1256-1262. |
[3] | XIA Yujia, YANG Zhenli, LIU Yuqin. Preclinical translational research and application of tumor organoids [J]. Basic & Clinical Medicine, 2024, 44(9): 1214-1218. |
[4] | LIU Baoqing, HUANG Rong, LU Yan, LI Kai, ZHANG Ning, LIU Changzheng, SONG Wei. Progress of gastric cancer organoids in basic research and clinical application [J]. Basic & Clinical Medicine, 2024, 44(9): 1219-1222. |
[5] | QIAN Xifeng, HUA Lu. Inflammatory cells and vascular remodeling in pulmonary arterial hypertension [J]. Basic & Clinical Medicine, 2024, 44(8): 1080-1087. |
[6] | GAO Chao, ZHANG Runhan, WANG Wei, ZHAO Manting, JIAO Yan, LI Zhe. Effect of artesunate on neuroinflammation in depressed mouse model by regulating cGAS-STING signaling pathway [J]. Basic & Clinical Medicine, 2024, 44(8): 1126-1132. |
[7] | LI Yang, ZHU Lei. Eukaryotic elongation factor 2 kinase is a potential new target for the treatment of tumors [J]. Basic & Clinical Medicine, 2024, 44(7): 1039-1043. |
[8] | CHEN Xiaotian, CHEN Chong, LUO Yunping. Impact of MAFB on polarization and function of tumor associated macrophages [J]. Basic & Clinical Medicine, 2024, 44(7): 965-973. |
[9] | ZHOU Yue, TONG Anli. Immune microenvironment of pheochromocytomas and paragangliomas [J]. Basic & Clinical Medicine, 2024, 44(6): 742-747. |
[10] | SHENG Qi, TONG Jin. The CXCL10/CXCR3 axis in acute respiratory distress syndrome [J]. Basic & Clinical Medicine, 2024, 44(6): 892-896. |
[11] | YE Yuxin, LI Huixian, YAN Tao, ZHANG Yun, SUN Yulin. Quantitative analysis of trace-level proteins for assessing inflammation through clinical sampling [J]. Basic & Clinical Medicine, 2024, 44(5): 690-698. |
[12] | ZHANG Liyuan, DU Hanze, PAN Hui. Progress in drug therapy for hypothalamic obesity [J]. Basic & Clinical Medicine, 2024, 44(5): 729-732. |
[13] | WANG Tingting, GUO Dan, LU Junyang, XU Lai, DONG Haitao, LIN Dianxin, XIAO Yi. Analysis of cell mutation types of colorectal neuroendocrine tumors [J]. Basic & Clinical Medicine, 2024, 44(4): 523-527. |
[14] | LEI Shaoyuan, LI Yulong, SUN Fei, LIU Hongjun, WU Yue, GUO Yansu. The epidemiology and prediction of brain tumors incidence and mortality in China [J]. Basic & Clinical Medicine, 2024, 44(4): 454-458. |
[15] | WU Yuhong, YU Caiyuan, YE Shicai. Research progress on the role of NMES1 gene in malignant tumors [J]. Basic & Clinical Medicine, 2024, 44(3): 403-407. |
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Full text 154
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Abstract 180
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||